Riskpilot← Back to searchSign inGet full accessPHARMPROTECH HOLDING ApS
APSActiveCVR 29174644Godtfreds Høje 6Activities of holding companies · NACE 6421Est. 2005— employees
Revenue 2025
DKK -767K
+369% vs 2024
EBITDA margin
100.0%
-369% vs 2024
Equity ratio
86.7%
Financial strength
Net profit 2025
DKK 3,6M
-39% vs 2024
| Revenue | DKK -767K | +369% |
| EBITDA | DKK -767K | -369% |
| Net profit | DKK 3,6M | -39% |
| Total assets | DKK 44M | +9% |
| Equity | DKK 38,1M | +10% |
| Employees | — | — |
Legal name
PHARMPROTECH HOLDING ApS
CVR number
29174644
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
14. november 2005
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er investering og kapitalanbringelse og dermed beslægtet virksomhed
Address
Godtfreds Høje 6
Phone
+4540954285
Email
toch@scantago.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -6 | 181 | 216 | 273 | 259 | 267 | 212 | -43 | -6 | -10 | -10 | -17 | -164 | -767 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1 | 181 | 216 | 273 | 259 | 267 | 212 | -43 | -6 | -115 | 95 | -17 | -164 | -767 |
| Depreciation & amort. | -0 | -32 | -38 | -38 | -38 | -38 | -38 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1 | 150 | 178 | 235 | 221 | 229 | 174 | -43 | -6 | -115 | 95 | -17 | -164 | -767 |
| Net financials | 1.063 | 319 | 1.091 | 972 | 1.644 | 1.416 | 1.870 | 1.936 | 5.440 | 1.383 | 5.557 | 5.282 | 6.153 | 4.391 |
| Profit before tax | 1.064 | 472 | 1.269 | 1.207 | 1.866 | 1.645 | 2.044 | 1.893 | 5.434 | 1.269 | 5.652 | 5.265 | 5.990 | 3.624 |
| Tax | 3 | 1 | 31 | 34 | 21 | 43 | 39 | -20 | -6 | -9 | 71 | 76 | 112 | 28 |
| Net profit | 1.061 | 470 | 1.238 | 1.174 | 1.845 | 1.602 | 2.006 | 1.913 | 5.440 | 1.278 | 5.581 | 5.190 | 5.878 | 3.595 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.805 | 4.678 | 5.822 | 7.384 | 9.079 | 9.952 | 12.895 | 14.058 | 26.120 | 22.703 | 27.632 | 34.680 | 40.531 | 43.995 |
| Equity | 1.667 | 2.089 | 3.278 | 4.403 | 6.198 | 7.750 | 9.704 | 11.563 | 16.844 | 18.066 | 23.589 | 28.779 | 34.598 | 38.132 |
| Long-term debt | 0 | 2.296 | 2.220 | 2.468 | 2.328 | 2.124 | 2.580 | 541 | 1.107 | 634 | 1.709 | 1.402 | 1.271 | 820 |
| Short-term debt | 138 | 235 | 233 | 481 | 516 | 108 | 553 | 1.954 | 8.169 | 4.003 | 2.333 | 4.499 | 4.662 | 5.043 |
| Total debt | 138 | 2.589 | 2.521 | 2.949 | 2.844 | 2.154 | 3.133 | 2.495 | 9.276 | 4.637 | 4.043 | 5.901 | 5.933 | 5.862 |
EBITDA margin
-76718800.0%
This company
15.8%
Market median
-485562125% vs market
20122025
Equity ratio
86.7%
This company
38.2%
Market median
+127% vs market
20122025
Return on equity
9.4%
This company
18.4%
Market median
-49% vs market
20122025
Net profit margin
359517900.0%
This company
8.1%
Market median
+4438492493% vs market
20122025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMPROTECH HOLDING ApS (this company)
A/S ELECTRO SERVICEBoard members of PHARMPROTECH HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|